Zur Kurzanzeige

2021-02-17Zeitschriftenartikel DOI: 10.25646/8798
Challenges in interpreting SARS-CoV-2 serological results in African countries
dc.contributor.authorNdaye, Antoine Nkuba
dc.contributor.authorHoxha, Ana
dc.contributor.authorMadinga, Joule
dc.contributor.authorMarien, Joachim
dc.contributor.authorPeeters, Martine
dc.contributor.authorLeendertz, Fabian H.
dc.contributor.authorMundeke, Steve Ahuka
dc.contributor.authorArien, Kevin K.
dc.contributor.authorTanfumu, Jean-Jaques Muyembe
dc.contributor.authorKingebeni, Placide Mbala
dc.contributor.authorVanlerberghe, Veerle
dc.date.accessioned2021-07-13T06:26:56Z
dc.date.available2021-07-13T06:26:56Z
dc.date.issued2021-02-17none
dc.identifier.other10.1016/S2214-109X(21)00060-7
dc.identifier.urihttp://edoc.rki.de/176904/8523
dc.description.abstractA diagnosis of COVID-19 is based on a positive PCR test for SARS-CoV-2. Over the past year, PCR testing capacity has varied globally due to the availability of tests, and testing strategies have targeted mainly symptomatic individuals. Therefore, the spread of the virus is probably wider than the numbers reported by official surveillance systems that are based on PCR results. Serology tests detect antibodies against SARS-CoV-2, which start being measurable around 1–2 weeks after infection. They are used in seroprevalence studies to estimate the proportion of people in a population that has been infected, including asymptomatic infection. These studies are of particular importance in African countries, where reported testing and incidence are among the lowest in the world.eng
dc.language.isoengnone
dc.publisherRobert Koch-Institut
dc.rights(CC BY-NC-ND 3.0 DE) Namensnennung - Nicht-kommerziell - Keine Bearbeitung 3.0 Deutschlandger
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/3.0/de/
dc.subject.ddc610 Medizin und Gesundheitnone
dc.titleChallenges in interpreting SARS-CoV-2 serological results in African countriesnone
dc.typearticle
dc.identifier.urnurn:nbn:de:kobv:0257-176904/8523-7
dc.identifier.doihttp://dx.doi.org/10.25646/8798
dc.type.versionpublishedVersionnone
local.edoc.container-titleThe Lancet Global Healthnone
local.edoc.container-issn2214-109Xnone
local.edoc.pages2none
local.edoc.type-nameZeitschriftenartikel
local.edoc.container-typeperiodical
local.edoc.container-type-nameZeitschrift
local.edoc.container-urlhttps://www.sciencedirect.com/science/article/pii/S2214109X21000607?via%3Dihubnone
local.edoc.container-publisher-nameElseviernone
local.edoc.container-volume9none
local.edoc.container-issue5none
local.edoc.rki-departmentProjektgruppen/Nachwuchsgruppennone
dc.description.versionPeer Reviewednone

Zur Kurzanzeige